Orphan Therapeutics Accelerator Expands its Network to Extend Development and Access Pathways for Ultra-Rare Disease Therapies

New collaborations add coordinated clinical research, manufacturing, regulatory strategy and access expertise to support advancement of stalled ultra-rare disease programs CAMBRIDGE, Mass., June 23, 2026 /PRNewswire/ -- Orphan Therapeutics Accelerator (OTXL), a non-profit biotech focused...